Initiation and duration of proton pump inhibitors in the Australian veteran population

Internal Medicine Journal

Volumn 42, Issue 5, 2012, Pages

  Gadzhanova, S V ^a   Roughead, E E ^a   Mackson, J M ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b National Prescribing Service Ltd   (Australia)

Author keywords

Australia; Duration; Gastro oesophageal reflux disease; Proton pump inhibitor

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

AGED; ARTICLE; AUSTRALIA; BILLING AND CLAIMS; COHORT ANALYSIS; FEMALE; GASTROESOPHAGEAL REFLUX; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT COMPLIANCE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TIME; TREATMENT DURATION; TREATMENT WITHDRAWAL; VETERAN;

AGED; AGED, 80 AND OVER; AUSTRALIA; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; TIME FACTORS; VETERANS;

EID: 84861429145     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02259.x     Document Type: Article

References (25)

1. Irvine E. Quality of life assessment in gastrooesophageal reflux disease. Gut 2004; 53: iv35-9.
2. Knox S, Harrison C, Britt H, Henderson J. Estimating prevalence of common chronic morbidities in Australia. Med J Aust 2008; 189: 66-70.
3. Armstrong D. Systematic review: persistence and severity in gastrooesophageal reflux disease. Aliment Pharmacol Ther 2008; 28: 841-53.
4. Piterman L, Nelson M, Dent J. Gastrooesophageal reflux disease: current concepts in management. Aust Fam Physician 2005; 33: 987-91.
5. Medicare Australia Statistics. Pharmaceutical Benefits Schedule Item Reports. [Cited 2009 Jun 25]. Available from URL:
6. Gastroenterological Society of Australia. Gastrooesophageal reflux disease in adults. Guidelines for clinicians. 3rd edition; 2001.
7. Rossi S (Ed.). Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd; 2004.
8. National Prescribing Service Limited. Proton pump inhibitors: too much of a good thing? Prescribing Practice Review 25. Apr 2004.
9. National Prescribing Service Limited. Proton pump inhibitors in primary care. Prescribing Practice Review 34. Jul 2006.
10. Veterans' MATES. PPIs in GORD: reduce the dose - keep the benefits. Therapeutic brief 7; Jun 2006; [cited 2009 May 28]. Available from URL:
11. Wong W, Lim P, Wong B. Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey. J Gastroenterol Hepatol 2004; 19: S54-60.
12. National Prescribing Service Limited. Optimising use of proton pump inhibitors - pre and post survey of GPs' knowledge and attitudes. Executive summary. Published 01/02/2005.
13. Grant K, Al-Adhami N, Tordoff J, Livesey J, Narbezat G, Reith D. Continuation of proton pump inhibitors from hospital to community. Pharm World Sci 2006; 28: 189-93.
14. Walker N, McDonald J. An evaluation of the use of proton pump inhibitors. Pharm World Sci 2001; 23: 116-17.
15. Roughead EE, Kalisch LM, Ramsay EN, Ryan P, Gilbert AL. Continuity of care: when do patients visit community healthcare providers after leaving hospital? Int Med J 2011; 41: 662-7.
16. Vitry A, Wong S, Roughead E, Ramsay E, Barratt J. Validity of medication-based co-morbidity indices in the Australian elderly population. Aust N Z J Public Health 2009; 33: 126-30.
17. Naunton M, Peterson G, Bleasel M. Overuse of proton pump inhibitors. J Clin Pharm Ther 2000; 25: 333-40.
18. Lee T, Fennerty M, Howden C. Systematic review: is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2004; 20: 1241-51.
19. Raghunath A, O'Morain C, McLoughlin R. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 2005; 22: 55-63.
20. Van Soest E, Siersema P, Dieleman J, Sturkenboom M, Kuipers E. Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 2006; 24: 377-85.
21. Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009; 137: 80-7.
22. Lloyd J, Anderson P; Australian Institute of Health and Welfare. Veterans' use of health services. Aged care series no. 13. Cat. no. AGE 51 Canberra: AIHW; 2008.
23. Commonwealth Department of Health and Ageing. PBS Expenditure and Prescriptions for 12months to 30 June 2008. Canberra: Australian Government; 2008; [cited 2010 Feb 18]. Available from URL:
24. Geevasinga N, Coleman P, Webster A etal. Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol 2006; 4: 597-604.
25. Roughead E, Ramsay E, Pratt N, Ryan P, Gilbert A. Proton-pump inhibitors and the risk of antiobiotic use and hospitalisation for pneumonia. MJA 2009; 190: 115-16.